Get started
Author

Ailing Qin

Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies
2022 · C.A. Powell, S. Modi, et al. · ESMO Open · 286
PDF
A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors
2016 · A.J. Wagner, H. Kindler, et al. · Annals of Oncology · 51
PDF
1205MO Updated analysis of DESTINY-Gastric02: A phase II single-arm trial of trastuzumab deruxtecan (T-DXd) in western patients (Pts) with HER2-positive (HER2+) unresectable/metastatic gastric/gastroesophageal junction (GEJ) cancer who progressed on or after trastuzumab-containing regimen
2022 · G.Y. Ku, M. Di Bartolomeo, et al. · Annals of Oncology · 30
PDF
LBA55 Primary analysis of a phase II single-arm trial of trastuzumab deruxtecan (T-DXd) in western patients (Pts) with HER2-positive (HER2+) unresectable or metastatic gastric or gastroesophageal junction (GEJ) cancer who progressed on or after a trastuzumab-containing regimen
2021 · E. van Cutsem, M. Di Bartolomeo, et al. · Annals of Oncology · 28
EAT‐Lancet Diet Pattern, Genetic Predisposition, Inflammatory Biomarkers, and Risk of Lung Cancer Incidence and Mortality
2024 · Fubin Liu, Changyu Si, et al. · Molecular Nutrition & Food Research · 21
289P Risk factors for interstitial lung disease in patients treated with trastuzumab deruxtecan from two interventional studies
2020 · C.A. Powell, D.R. Camidge, et al. · Annals of Oncology · 21
Metabolic dysfunction‐associated steatotic liver disease and cancer risk: A cohort study
2025 · Yu Peng, Peng Wang, et al. · Diabetes Obesity and Metabolism · 19
Integrated analysis of microbiota and gut microbial metabolites in blood for breast cancer
2024 · Yu Peng, Jiale Gu, et al. · mSystems · 19
92O Analysis of study drug-related interstitial lung disease (ILD) in patients (pts) with HER2+ metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd)
2021 · C.A. Powell, S. Modi, et al. · Annals of Oncology · 17
Association Between Volume, Intensity and Rhythm of Physical Activity Measured by Accelerometer and Risk of All‐Cause and Cause‐Specific Mortality in Individuals With MASLD
2025 · Yu Peng, Fubin Liu, et al. · Alimentary Pharmacology & Therapeutics · 6
PDF
A randomized phase 1b/2 study evaluating the safety and efficacy of doxorubicin (dox) with or without olaratumab (IMC-3G3), a human anti–platelet-derived growth factor &agr; (pdgfr&agr;) monoclonal antibody, in advanced soft tissue sarcoma (sts)
2016 · W. Tap, R.L. Jones, et al. · Annals of Oncology · 6
PDF
472 A phase I study of IMGN388, an antibody drug conjugate targeting av integrin, in patients with solid tumors
2010 · J. Bendell, K. Moore, et al. · European Journal of Cancer Supplements · 5
510 POSTER Phase I study of IMGN901 (BB-10901) in patients with CD56-positive solid tumours
2008 · P. Woll, F. Fossella, et al. · European Journal of Cancer Supplements · 5
Sex disparity in the association between metabolic-anthropometric phenotypes and risk of obesity-related cancer: a prospective cohort study
2024 · Jianxiao Gong, Fubin Liu, et al. · BMC Medicine · 4
PDF
PI-13Pharmacokinetics and pharmacodynamics of a HER2 tyrosine kinase inhibitor CP-724714 in patients with advanced malignant HER2 positive solid tumors
2006 · F GUO, S LETRENT, et al. · Clinical Pharmacology & Therapeutics · 2
1574P Trastuzumab deruxtecan versus ramucirumab and paclitaxel as second-line therapy for patients with her2-positive gastric or gastro-esophageal junction adenocarcinoma: A propensity score matched comparison
2023 · R.H.A. Verhoeven, S. Kuijper, et al. · Annals of Oncology · 1
P-184 A phase 2 trial of trastuzumab deruxtecan (T-DXd, DS-8201) in patients with HER2-positive, unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma
2020 · C. Fuchs, J. Shahidi, et al. · Annals of Oncology · 1
Abstract 5040: Dietary advanced glycation end-products and risks of lung cancer and chronic respiratory diseases
2026 · Ailing Qin, Fubin Liu, et al. · Cancer Research
Abstract 2346: Association of serum creatinine- and cystatin c-based diagnostic indices for sarcopenia with major chronic diseases
2025 · Fangfang Song, Huijun Zhou, et al. · Cancer Research
Works count: 19
Citation count: 512
H-index: 9
I10-index: 9
Year
Topic
Type